CoreAge Rx vs Somira Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Somira Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Somira Health a bad call — it's best for readers who want to compare compounded formulations and will verify their pharmacy, full payment and renewal settings first. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Somira Health |
|---|---|---|
| Brief Score | 94/100 (A) | 64/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Current selected-plan quote unconfirmed Compounded injection with B12 or glycine options described; earlier $190/month listing is historical. Access and consultation fees can become nonrefundable before pharmacy transmission. Most plans can auto-renew; pausing alone may not stop charges. Full price detailsCompounded semaglutide injections offered with B12 or glycine options; complete current selected-plan quote unknown; earlier listing from $190/mo is historical |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Current selected-plan quote unconfirmed Compounded injection with B12 or glycine options described; earlier $285/month listing is historical. Access and consultation fees can become nonrefundable before pharmacy transmission. Most plans can auto-renew; pausing alone may not stop charges. Full price detailsCompounded tirzepatide injections offered with B12 or glycine options; complete current selected-plan quote unknown; earlier listing from $285/mo is historical |
| Coverage | US only; restrictions by state, confirmed at intake | Provider network advertises 50 states, D.C. and Puerto Rico; actual treatment access also requires compliant pharmacy fulfillment |
| Brand-name access | Not confirmed | Branded drug labeling is linked for safety information; it does not establish a current branded-medication program. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Somira Health: Complete selected-plan price unconfirmed. Plans may auto-renew; access and consultation fees have earlier refund cutoffs than pharmacy transmission. Confirm each charge before paying.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.